论文部分内容阅读
作者报告218例符合FIGO分期的Ⅰ、Ⅱ期子宫颈癌用标准疗法观察盆部淋巴结对预后的影响,其中214例(98%)至少随诊5年,仅4例失访。标准疗法是:先在1、7和21天宫腔上镭或铯各1次,每次持续24小时,A点剂量相当于2,200cGy。4～6周后作Wertheim子宫切除与盆部淋巴结清扫术,如盆部淋巴结组织学阳性,则给予外照射:用兆压机,前后对穿野,中线量3,600cGy/12次/28天,如宫腔源照射量超过6,000cGy,则中央部给予屏蔽。结果:42例(23%)盆部淋巴结组织学显示阳性,其中23例(55%)死于癌,而139例淋巴结阴性者仅13例(9%)死于癌。腔内治疗后在作We-
The authors reported that 218 cases of stage I and II cervical cancer meeting the FIGO staging were treated with standard therapy to assess the effect of pelvic lymph node metastasis on prognosis, of which 214 (98%) were followed up for at least 5 years and only 4 were lost. The standard regimen is: first in the uterus 1, 7 and 21 days radium or cesium each 1 time, each time for 24 hours, A dose equivalent to 2,200 cGy. Wertheim hysterectomy and pelvic lymphadenectomy were performed 4-6 weeks later. If pelvic lymph node histology was positive, external irradiation was given: with a mega-press, anteroposterior diameter of 3,600cGy / 12 times / 28 days, If the uterine source exposure of more than 6,000 cGy, the central part of the shield. RESULTS: Twenty-four patients (23%) had positive histological findings of pelvic lymph nodes, of which 23 (55%) died of cancer and only 13 (9%) of 139 lymph node-negative patients died of cancer. Endovascular treatment in the We-